619.541.6609

We are available 24/7

CLAIMS ASSISTANCE 619.541.6609

Tirzepatide claim eligibility for injured consumers

Tirzepatide

What is tizepatide?

Tirzepatide is a gastric inhibitory polypeptide analog and GLP-1 receptor agonist. Eli Lilly and Company developed this active agent, which is used in Mounjaro and Zepbound to help people who suffer from Type 2 Diabetes, obesity, and weight-related medical problems or OSA. Tirzepatide is FDA-approved, meaning people can acquire it at any drug store as long as they have a doctor’s prescription; however, it also has negative side effects that could potentially cause harm to patients. 

New research from NCBI indicates that the frequency and severity of gastrointestinal symptoms in type 2 diabetes patients receiving tirzepatide have significantly increased. One notable risk is gastroparesis (stomach paralysis), which appears to be a severe side effect of the drug.

If you have taken tirzepatide and developed gastroparesis, bowel obstruction, or vision loss, experienced persistent vomiting for weeks, or were hospitalized or visited the ER while taking it do not hesitate to reach out to us. You might be eligible for compensation for any injury that tirzepatide has caused you.

How Tirzepatide causes injuries

According to a new study published in the National Library of Medicine, data from six randomized controlled trials with a total of 4,586 patients with a dose of tirzepatide ranging from 5mg, 10mg, and 15mg weekly revealed that the risk ratio for developing gastroparesis was significant. Gastroparesis (stomach paralysis) is a very serious medical condition that can lead to complications and even permanent injuries. It is also called delayed gastric emptying and it is a disorder that slows or stops the movement of food from your stomach to your small intestine, even though there is no blockage in the stomach or intestines.

Eligibility for Tirzepatide claims

Whether you have type 2 diabetes or are just overweight and taking tirzepatide, and you’ve suddenly developed stomach paralysis or bowel obstruction, there is a high probability that these are the side effects of the drug. If your medical records confirm you suffering from gastroparesis, you are eligible to file a tirzepatide claim,  which could help offset your medical expenses. 

Atraxia Law has a knowledgable team that can thoroughly and carefully review your case to see if you’re eligible for a tirzepatide claim. Should Atraxia Law find grounds for manufacturer liability in your case and if you are willing to work with us to file a claim, then you must meet the following criteria:

You can also contact us to see if you are eligible to file a tirzepatide claim if you experienced persistent vomiting (at least 4 weeks) with hospitalization and/or ER visits while taking the drug or within 60 days of stopping and if you were hospitalized for any gastric issue while using tirzepatide.

Tirzepatide claims, settlements, and litigation

Tirzepatide has caused severe medical-related injuries and already, lawsuits are being filed by law firms all over court dockets. The plaintiffs and families of injured loved ones allege that people taking tirzepatide may be at risk of developing gastroparesis and gastrointestinal obstruction. Tirzepatide injuries can result from drug complications, including serious stomach problems, gallbladder problems, kidney failure, pancreatitis, and thyroid cancer.

One of the claims filed states that Eli Lilly may have prior knowledge of the dangers of their products, but deliberately ignored it and went ahead to do human trials.

File a Tirzepatide claim with Atraxia Law

Atraxia Law is currently handling tirzepatide claims across all 50 states. If you or someone close to you were diagnosed with stomach paralysis, bowel obstruction, or vision loss after taking tirzepatide, contact us. We can check your case if you meet the eligibility criteria for a tirzepatide claim, we are here to help.

Free case evaluation

10 Minutes Over the Phone

*No fees unless compensation is obtained

EVALUATE MY CASE NOW